NCT02721732 2026-01-29
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT04231981 2025-05-29
ORPHEUS
MedSIR
Phase 2 Completed
NCT05959564 2024-10-21
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
University of Maryland, College Park
Phase NA Completed
NCT03439085 2024-07-09
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03856437 2024-03-15
A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
University of Maryland, College Park
Phase NA Completed
NCT02837042 2022-06-21
Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
University of Alabama at Birmingham
Phase 2 Terminated
NCT00955929 2021-11-10
Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
Memorial Sloan Kettering Cancer Center
Phase NA Terminated
NCT00512096 2012-08-01
Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
M.D. Anderson Cancer Center
Phase 2 Completed